Preparation of GM1 ganglioside with sialidase-producing marine bacteria as a microbial biocatalyst

Applied and Environmental Microbiology

Volumn 63, Issue 5, 1997, Pages 1861-1865

  Fukano, Yasufumi ^a   Ito, Makoto ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE GM1; SEA WATER; SIALIDASE;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CATALYST; CULTURE MEDIUM; ENZYME ASSAY; ENZYME PURIFICATION; ENZYME SYNTHESIS; MARINE ENVIRONMENT; NERVE FIBER GROWTH; NONHUMAN; PSEUDOMONAS; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 0030959844     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.63.5.1861-1865.1997     Document Type: Article

References (27)

1. Ada, G. L., E. L. French, and P. E. Lind. 1961. Purification and properties of neuraminidase from Vibrio cholerae. J. Gen. Microbiol. 24:409-421.
2. Argentino, C., M. L. Sacchetti, D. Toni, G. Savoini, E. D'Arcangelo, F. Erminio, F. Federico, F. F. Milone, V. Gallai, D. Gambi, A. Mamoli, G. A. Ottonello, O. Ponari, G. Rebucci, U. Senin, and C. Fieschi. 1989. GM1 ganglioside therapy in acute ischemic stroke. Stroke 20:1143-1149.
3. Arita, M., M. Iwamori, T. Higuchi, and Y. Nagai. 1983. Negative ion fast atom bombardment mass spectrometry of gangliosides and asialo gangliosides: a useful method for the structural elucidation of gangliosides and related neutral glycosphingolipids. J. Biochem. 94:249-256.
4. Bremer, E. G., S. Hakomori, D. F. Bowen-Pope, E. Raines, and R. Ross. 1984. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J. Biol. Chem. 259:6818-6825.
5. Bremer, E. G., J. Schlessinger, and S. Hakomori. 1986. Ganglioside-mediated modulation of cell growth. J. Biol. Chem. 261:2434-2440.
6. Buchanan, R. E. and N. E. Gibbons (ed.). 1974. Bergey's manual of determinative bacteriology, 8th ed. The Williams & Wilkins Co., Baltimore, Md.
7. Cassidy, J. T., G. W. Jourdian, and S. Roseman. 1965. The sialic acids. Purification and properties of sialidase from Clostridium perfringens. J. Biol. Chem. 240:3501-3506.
8. 2+ channel-linked release of γ-aminobutyric acid in rat brain slices. J. Neurochem. 48:1048-1052.
9. Geisler, F. H., F. C. Dorsey, and W. P. Coleman. 1991. Recovery of motor function after spinal-cord injury. A randomized, placebo-controlled trial with GM1 ganglioside. N. Engl. J. Med. 324:1829-1838.
10. Hugh, R., and E. Leifson. 1953. The taxonomic significance of fermentative versus oxidative metabolism of carbohydrates by various gram-negative bacteria. J. Bacteriol. 66:24-20.
11. Ito, M., T. Kurita, and K. Kita. 1995. A novel enzyme that cleaves the N-acyl linkage of ceramides in various glycosphingolipids as well as sphingomyelin to produce their lyso forms. J. Biol. Chem. 270:24370-24374.
12. Kanfer, J. N. 1969. Preparation of gangliosides. Methods Enzymol. 14:660-664.
13. Kita, K., S. Mitsutake, and M. Ito. Unpublished data.
14. Kovacs, N. 1956. Identification of Pseudomonas pyocyanea by the oxidase reaction. Nature (London) 178:703.
15. Ledeen, R. W. 1984. Biology of gangliosides: neuritogenic and neuronotrophic properties. J. Neurosci. Res. 12:147-159.
16. Ledeen, R. W. 1989. Biosynthesis, metabolism, and biological effects of gangliosides, p. 43-83. In R. U. Margolis and R. K. Margolis (ed.), Neurobiology of glycoconjugates. Plenum Press, New York, N.Y.
17. Nakamura, K., and S. Handa. 1984. Coomassie brilliant blue staining of lipids on thin-layer plates. Anal. Biochem. 142:406-410.
18. Nojiri, H., M. Stroud, and S. Hakomori. 1991. A specific type of ganglioside as a modulator of insulin-dependent cell growth and insulin receptor tyrosine kinase activity. J. Biol. Chem. 266:4531-1537.
19. Partington, C. R., and J. W. Daly. 1979. Effect of gangliosides on adenylate cyclase activity in rat cerebral cortical membranes. Mol. Pharmacol. 15:484-491.
20. Paulson, J. C., J. Weinstein, L. Dorland, H. van Halbeek, and J. F. G. Vliegenthart. 1982. Newcastle disease virus contains a linkage-specific glycoprotein sialidase. J. Biol. Chem. 257:12734-12738.
21. Schneider, J. S., D. P. Roeltgen, D. S. Rothblat, J. Chapas-Crilly, L. Seraydarian, and J. Rao. 1995. GM1 ganglioside treatment of Parkinson's disease: an open pilot study of safety and efficacy. Neurology 45:1149-1154.
22. Svennerholm, L. 1963. Chromatographic separation of human brain gangliosides. J. Neurochem. 10:613-623.
23. Svennerholm, L. 1994. Gangliosides. A new therapeutic agent against stroke and Alzheimer's disease. Life Sci. 55:2125-2134.
24. Uchida, Y., Y. Tsukada, and T. Sugimori. 1979. Enzymatic properties of neuraminidases from Arthrobacter ureafaciens. J. Biochem. 86:1573-1585.
25. Wakai, H., A. Murata, K. Kon, K. Maruyama, S. Kimura, H. Ogura, and S. Ando. 1993. Isolation and characterization of a trisialyllactosylceramide, GT3, containing an O-acelylated sialic acid in cod fish brain. J. Biochem. 113:502-507.
26. Wu, G., and R. W. Ledeen. 1991. Stimulation of neurite outgrowth in neuroblastoma cells by neuraminidase: putative role of GM1 ganglioside in differentiation. J. Neurochem. 56:95-104.
27. Zheng, M., H. Fang, T. Tsuruoka, T. Tuji, T. Sasaki, and S. Hakomori. 1993. Regulatory role of GM3 ganglioside in α5β1 integrin receptor tor fibronectin-mediated adhesion of FUA169 cells. J. Biol. Chem. 268:2217-2222.